CNX Therapeutics | B Corp™ Certified Revenue

Pharmaceutical Manufacturing • London, England, United Kingdom • 51-100 Employees

CNX Therapeutics | B Corp™ Certified revenue & valuation

Annual revenue	$5,988,850
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$19,200,000
Total funding	No funding

Key Contacts at CNX Therapeutics | B Corp™ Certified

Guy Clark

Chief Executive Officer

Jamie Corbridge

People Director

Matthew Way

Supply Chain Director

Dorota Allard Gronostajska

Director Of Regulatory Affairs

Alison Comber

Director, Special Projects & Alliance Manager

Company overview

Headquarters	LABS House, 15-19 Bloomsbury Way, London, WC1A 2TH, GB
Phone number	+442078212840
Website	cnx-therapeutics.com
NAICS	3254
SIC	283
Founded	2021
Employees	51-100
Socials

CNX Therapeutics | B Corp™ Certified Email Formats

CNX Therapeutics | B Corp™ Certified uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@cnx-therapeutics.com), used 55.8% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@cnx-therapeutics.com	55.8%
{first initial}.{last name}	j.doe@cnx-therapeutics.com	44.2%

About CNX Therapeutics | B Corp™ Certified

CNX Therapeutics is a European pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines. We license and distribute a portfolio of medicines for CNS, critical care and other conditions, both directly and through strategic partnerships, in over 60 countries worldwide. A certified B Corp company, our vision is to become a recognised partner of choice through our commercial excellence, patient focus and presence across Europe.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Manager

Entry

C-Suite

Employees by Department

CNX Therapeutics | B Corp™ Certified has 36 employees across 9 departments.

Departments

Number of employees

Funding Data

CNX Therapeutics | B Corp™ Certified has never raised funding before.

CNX Therapeutics | B Corp™ Certified Tech Stack

Discover the technologies and tools that power CNX Therapeutics | B Corp™ Certified's digital infrastructure, from frameworks to analytics platforms.

SiteGround

Hosting

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Cloudflare Rocket Loader

Performance

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

anime.js

JavaScript graphics

Google Analytics

Analytics

Yoast SEO

SEO

Frequently asked questions

CNX Therapeutics | B Corp™ Certified is located in London, England, GB.

You can reach CNX Therapeutics | B Corp™ Certified at +442078212840.

CNX Therapeutics | B Corp™ Certified generates an estimated annual revenue of $5,988,850. This revenue figure reflects the company's market position and business performance in its industry.

CNX Therapeutics | B Corp™ Certified has an estimated valuation of $19,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

CNX Therapeutics | B Corp™ Certified was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

CNX Therapeutics | B Corp™ Certified has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.